ABVD or BEACOPPbaseline along with involved-field radiotherapy in early-stage Hodgkin Lymphoma with risk factors: Results of the European Organisation for Research and Treatment of Cancer (EORTC)-Groupe d'Étude des Lymphomes de l'Adulte (GELA) H9-U intergroup randomised trial.

European Journal of Cancer（2017）

引用 30|浏览38

暂无评分

摘要

•4 cycles of ABVD and IFRT 30Gy not inferior to 6-ABVD-IFRT in terms of efficacy.•4 cycles of BEACOPPbaseline have similar efficacy but more toxic than 4–6 ABVD.•4 cycles of ABVD is reference chemotherapy in early-stage HL with risk factors.

查看译文

关键词

Hodgkin lymphoma,Early stage,Chemotherapy,Radiotherapy,Treatment efficacy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要